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Abstract In order to evaluate the incidence of community-
associated methicillin-resistant Staphylococcus aureus (CA-
MRSA) in Portugal, we analyzed a collection of 38 S.
aureus isolates recovered from 30 children attending the
pediatric emergency department of a central hospital in
Lisbon due to skin and soft tissue infections. Molecular
characterization identified seven clonal lineages among the
35 methicillin-susceptible S. aureus (MSSA) isolates, of
which the major lineage PFGE A/t159/ST121 included
63% of the isolates. The three MRSA isolates belonged to
the Pediatric clone PFGE D/t535/ST5-IV (n=2) and to the
European CA-MRSA clone PFGE G/t044/ST80-IVc (n=1).
All isolates harbored several virulence factors, namely,
leukocidins. Panton–Valentine leukocidin (PVL) was pro-
duced by isolates from five MSSA lineages and by the
ST80 MRSA. Of interest, this is the first reported isolation
of CA-MRSA ST80 in Portugal.
Methicillin-resistant Staphylococcus aureus (MRSA) infec-
tions in the community have been increasing worldwide
and are mainly reported as skin and soft tissue infections
(SSTI) in otherwise healthy young individuals [1–3]. The
Centers for Disease Control and Prevention (CDC) consider
a community-associated MRSA (CA-MRSA) infection
when the patient has no previous history of MRSA
infection or colonization, surgery, dialysis, hospitalization,
residence in a long-term care facility within the year before
infection, presence of a percutaneous device or indwelling
catheter, or hospitalization >48 h before MRSA cultures
[4, 5].
CA-MRSA isolates differ phenotypically and genotypi-
cally from hospital-associated (HA-) MRSA, namely, in its
non-multiresistant antibiotic patterns, enhanced virulent
gene content, including the acquisition of the necrotizing
Panton–Valentine leukocidin (PVL) genes or the expression
of α-type phenol-soluble modulins (PSMs) [1, 3]. The
staphylococcal cassette chromosome mec (SCCmec) type
and the accessory gene regulator (agr) alleles are also
differentially distributed: SCCmec types IV or V and agr
type III are more commonly present in CA-MRSA, while
SCCmec types I–III and agr type II are more typical of HA-
MRSA [1]. In contrast, community-acquired methicillin-
susceptible S. aureus (CA-MSSA) isolates, responsible for
a significant number of mild SSTI, do not differ from HA-
MSSA [6, 7].
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Although reports of CA-MRSA prevalence are increas-
ing worldwide, there is no description of the actual scenario
in Portugal, a country with >50% HA-MRSA infection,
currently the highest in Europe [8]. Previous studies dated
from 1996 to 2009, including isolates from nasal swabs of
young healthy individuals and nasopharyngeal swabs of
children attending day care centers, reported an MRSA
prevalence lower than 0.25% in the Portuguese healthy
community (0.24% in 1996–1998 and 0.13% in 2006–
2009) [6, 9, 10].
It is conceivable that the incidence of CA-MRSA in
Portugal is underestimated partially because skin infection
samples are not routinely cultured.
The aim of the present study was to assess the
prevalence and molecular characterization of S. aureus in
children attending the pediatric emergency department of a
central hospital due to SSTI.
The pediatric emergency department of Hospital
Fernando Fonseca, a large tertiary-care hospital (670 beds),
is the second largest pediatric urgency unit in the urban area
of Lisbon, Portugal, and receives approximately 180 children
per day. Between August 2005 and October 2006, all children
attending this unit due to SSTI were enrolled in the study.
Samples were recovered by swabbing the largest area of skin
infection or wounds with spontaneous or surgical drainage, or
in case of severe SSTI from hemoculture. Whenever possible,
nasal swabs were also performed. A questionnaire was filled
in order to collect data on basic socio-demographic patient
information, risk factors associated with skin infection, and
description of the infection.
S. aureus isolates were first identified by conventional
coagulase and catalase tests. Additional identification and
susceptibility testing with a panel of 10 antibiotics (Fig. 1)
were performed by the semi-automatic VITEK2 system
(bioMérieux, SA, France) and the disk diffusion method for
clindamycin [11]. All isolates were tested by polymerase
chain reaction (PCR) for the presence of mecA [12] and
were also characterized by pulsed-field gel electrophoresis
(PFGE) [13]. The resulting SmaI patterns were analyzed by
both visual inspection and automatically with BioNumerics
software version 4.61 (Applied Maths, Sint-Martens-Latem,
Belgium) [14, 15]. Characterization by spa typing, multi-
locus sequence typing (MLST), and the agr allele type were
performed on representative isolates of each PFGE type
[16–18]. The SCCmec was typed for all MRSA isolates
[19, 20]. Specific staphylococcal virulence determinants,
including leukocidins, hemolysins, and super-antigenic
toxins of each isolate, were determined by PCR [21, 22]
(Fig. 2). Categorical variables were compared using the χ2
or Fisher’s exact test when appropriate, considering
p-values of ≤0.05 being statistically significant, and odds
ratio (OD) estimates using the SPSS software package
version 11.5 (SPSS Inc., Chicago, IL, USA).
During the 15-month study period, 30 (73.2%) out of the
41 children who attended the emergency department due to
SSTI were infected by S. aureus. The major clinical
infection presentations were cutaneous abscesses (n=12,
40%) and cellulitis (n=10, 33.33%). A total of 38 isolates
were recovered, of which three (7.9%) were MRSA.
Although eight clonal types (Table 1) were identified
among the isolates, 63% (n=19) belonged to a single type:
PFGE A, spa type t159, sequence type (ST) 121, agr type
IV. The ST121 lineage was also the predominant lineage
found in MSSA isolates through Europe and Russia [23–
25] and an identical scenario has been reported among
Asiatic children in both carriage and disease isolates, and
frequently associated to PVL. Of major concern was the
local emergence of methicillin resistance in ST121 isolates
in these pediatric communities: one MRSA isolate, PVL-
negative responsible for staphylococcal scalded skin
syndrome in China and two MRSA, PVL-positive, SCCmec
type V isolates responsible for osteomyelitis and soft tissue
abscess in Cambodia [26, 27]. Moreover, single ST121
MRSA isolates were reported in China (http://saureus.mlst.
net/) and the United States [28].
Retrospectively, all STs found in the present study (with
the exception of ST152) have already been described in
carriage among the Portuguese community in 1996,
although with a different prevalence [6]. Despite the small
size of the collection, the major CA-MSSA clones
described in Europe, ST1, ST5, ST30, and ST45 [29], were
found in the pediatric Portuguese community (Table 1).
Moreover, all clonal lineages, with the exception of PFGE
H/t084/ST582/agrIV, were recently reported among a
geographical and temporal diverse collection of 211 PVL-
positive CA-MSSA [23]. ST1/t127, the sixth most frequent
type among MSSA isolates recovered in 26 European
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Fig. 1 Antimicrobial susceptibility of the 38 Staphylococcus aureus
isolates to a panel of 10 antibiotics. Abbreviations: S, susceptible;
R, resistant; na, not available; OXA, oxacillin; PEN, penicillin;
AMC, amoxicillin–clavulanic acid; CIP, ciprofloxacin; ERY, erythro-
mycin; CLI, clindamycin; TET, tetracycline; GEN, gentamicin; SXT,
trimethoprim–sulfamethoxazole; VAN, vancomycin. All of the resistant
phenotypes observed for clindamycin mean inducible resistance,
determined by the D-test [11]
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countries [29], was also found in the present collection. In
the same work, Grundmann et al. showed that European
MSSA isolates belonged to more diverse genetic back-
grounds and have a wide geographical distribution com-
pared to MRSA, which have a predominantly regional
spread of a few pandemic clones [29].
A non-multiresistant antibiotic pattern is common in the
present collection (Fig. 1). Clindamycin and trimethoprim–
sulfamethoxazole (SXT) are rational empiric choices for
mild-to-moderate CA-MRSA infections [30]. However, a
positive D-test result in erythromycin-resistant isolates
indicates that clindamycin resistance may emerge during
therapy and, therefore, should not be prescribed [31, 32].
The detection of clindamycin inducible resistance in all
erythromycin-resistant isolates (n=10) raises some con-
cerns about the antibiotherapy available for the treatment of
children, namely, since resistance to STX was found in
three isolates from children with no previous hospitalization.
As far as we know, the single tetracycline-resistant
strain, HFF189, was the first MRSA ST80 (known as the
European CA-MRSA clone), PVL-positive described in
Portugal. Nevertheless, since it was recovered from a
periumbilical exudate of a neonate, the connection to the
nosocomial setting could not be discarded, as ST80 PVL-
positive isolates were already described as nosocomial
isolates in the late 1990s [33]. Regular surveillance studies
in Portuguese hospitals [34], together with the present
study, seem to indicate that CA-MRSA-ST80 is not widely
spread in Portugal in contrast to what was described in
several other European countries [21, 35].
Interestingly, the remaining two MRSA isolates,
PVL-negative, showed ST5-SCCmec type IV typical of
the Pediatric clone, described for the first time in a
Portuguese pediatric hospital [36]. The spread in the
community of a typical HA-MRSA lineage raises some
concern about the changing epidemiology of MRSA, and
Table 1 Molecular characterization and clinical presentation of the clonal lineages found among the 38 Staphylococcus aureus isolates recovered
during the 15-month study period
No. of
isolates
PFGE types (no.
of subtypes)
spa
typea
MLSTb SCCmec
type
PVL agr
type
Related clonec Clinical presentation (no. of isolates)
ST CC
19 A (8) t159 121 121 MSSA − IV Cellulitis (9), cutaneous abscess (3),
impetigo (1), wound (1), nasal swab (5)
6 B (4) t318 30 30 MSSA + III Southwest
Pacific
Cutaneous abscess (6)
3 C (3) t576 45 45 MSSA − I Berlin Cutaneous abscess (2), cellulitis (1)
2 D (1) t535 5 5 IVc − II Pediatric Impetigo (1), bacteremia (1)
1 D (1) t311 5 5 MSSA + II Pediatric Cutaneous abscess (1)
3 E (2) t355 152 152 MSSA + I Cutaneous abscess (1), cellulitis (1),
adenophlegmon (1)
2 F (2) t127 1 1 MSSA + III Cutaneous abscess (1), pustule (1)
1 G t044 80 80 IVc + III European Pustule (1)
1 H t084 582 15 MSSA − IV Impetigo (1)
a Ridom nomenclature (http://spaserver.ridom.de/)
bMLST, multilocus sequence typing; ST, sequence type; CC, clonal complex, defined by eBURST v3, assessed on 12 April 2010
c Common designation of community- or hospital-associated MRSA or MSSA clones
1 - 49% 50 - 99%0% 100%
PVL LukM LukDE β-hemol γ-hemol γ-hemol
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Fig. 2 Virulence gene determi-
nants of the eight clonal lineages.
The totality of the isolates was
tested for 11 virulence genes.
Abbreviations: PVL, Panton–
Valentine leukocidin; LukM, leu-
kocidin M; LukDE, leukocidins
D and E; β-hemol, β-hemolysin;
g-hemol, g-hemolysin; g-hemol
var, g-hemolysin variant; ETA,
ETB, ETD, exfoliative toxins A,
B, and D, respectively; SEL,
SEP, staphylococcal enterotoxins
L and P, respectively
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the blurring of the boundaries between the hospital and the
community.
All of the isolates presented virulence determinants,
namely, leukocidins (Fig. 2). Recently, a mechanism of
PVL-induced acute lung injury and lung inflammation in
rabbit models resolved the controversy about the role of
PVL as a key factor in S. aureus infection [37]. In our
study, isolates producing PVL or g-hemolysin were mainly
associated to cutaneous abscesses (p=0.003 and p=0.000,
respectively), as has already been reported in recent studies
in children infections [38, 39]. Conversely, the production
of β-hemolysin, ETA, or ETB seemed to be associated with
cellulitis (p=0.010, p=0.003, and p=0.038, respectively)
(data not shown).
No significant positive association was found between
socio-demographic data or possible risk factors for S.
aureus infection, possibly due to the small dimension of
the collection (data not shown).
MSSA infections, independently of the PVL content,
frequently show similar epidemiological and clinical char-
acteristics to MRSA, but specific PVL-positive MSSA
lineages are dynamically interrelated and recently reported
as reservoirs of CA-MRSA [23, 40]. Therefore, a regular
surveillance of SSTI, namely, in children, is critical in order
to predict and control the emergence of methicillin
resistance and spread of staphylococcal infections in the
community.
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